InvestorBrandNetwork
Bio
The InvestorBrandNetwork (IBN) is comprised of 40+ investor focused brands and offers a comprehensive suite of corporate communications solutions that reach new audiences on an ongoing focus basis. Full disclaimers: http://bit.ly/2S7w1sC
Stories (752/0)
SRAX Inc. (NASDAQ: SRAX) Announces Blockchain and Digital Media Expert Lou Kerner as CEO of BIGtoken
BIGtoken, a data marketplace that allows users to own and earn from their data, creates data sets that can be accessed by marketers for a fee BIGtoken to be spun off into its own publicly-traded company through definitive agreement with Force Protection Video Equipment Corp.
By InvestorBrandNetwork2 years ago in The Chain
Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) Stands to Benefit from Explosive Growth in Electric Vehicle Copper Demand
Electric vehicle sales are set to rise by 50% YoY in 2021, with global EV penetration rates forecast to touch 31% by 2030 Electric vehicles require nearly 80kg of copper during production process versus approximately 25 kilos for internal combustion engine powered vehicle Surge in long-term copper demand bodes favorable for Josemaria Resources, with company reportedly attracting attention of global mining giants in recent months
By InvestorBrandNetwork2 years ago in Trader
MAZAKALI Celebrates Optimism Trend in Cannabis Markets, Anticipates Decade-defining Asset Class
A supportive presidential administration along with continued state-level legalization is serving as a boon to cannabis market interests Professional sports leagues have become increasingly friendly to player use, reducing or eliminating cannabis-related drug testing protocols and punishments Market analysts forecast global revenues of $358.8 billion by 2027, an annual growth rate of 14.3% percent over 2020’s valuation. In the United States, the industry is growing at nearly twice that rate – boasting a projected annual growth of 27% over the next five years
By InvestorBrandNetwork2 years ago in Potent
Autonomous Security Robots Showcase Knightscope, Inc.’s Focus on Market Logical Use of Self-Driving Tech
Knightscope’s AI-enhanced robot sentries have been deployed to Fortune 1000 companies, hospitals, police departments, municipalities, utilities and casinos The company’s models include stationary robots as well as mobile products that patrol indoor and outdoor locations The robots use artificial intelligence and feature 360-degree eye-level HD streaming video, autonomous recharging, face and license plate recognition, and infrared thermal detection to deter crime and transmit safety or investigational information The sentries have the added benefit of being unaffected by the infectious contagion hampering the performance of many employees while the COVID pandemic remains in effect
By InvestorBrandNetwork2 years ago in Trader
Gage Cannabis Co. Rapidly Expands Retail Footprint as Michigan Celebrates Legalized Recreational Marijuana’s One Year Anniversary
Retailers have sold approximately $450 million worth of recreational marijuana products over the last year, with sales averaging $13 million per week in recent months Gage Cannabis has leveraged upon rising growth rate through rapid store expansion, which will see its store footprint grow by over 10 locations in 2021 Michigan’s governor recently signed legislation which will allow veterinarians to speak to pet owners about giving cannabis to their animals for therapeutic use
By InvestorBrandNetwork2 years ago in Potent
Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Offers Significant Advantages Over Current Standard Of Visualizing Bladder Cancer During Surgery
White light, the most widely accepted current standard of care for bladder cancer removal, may not be the best option in helping to prevent recurrence, leaving hundreds of thousands of patients afraid of relapse Blue light has been introduced and proven to detect 25% more tumors, but because of limitations, has not been widely accepted Imagin Medical’s i/Blue Imaging System(TM) can be used alongside the current surgical endoscopic tools for a side-by-side comparison of both white and blue-light imaging in real time
By InvestorBrandNetwork2 years ago in Longevity
Brain Scientific (BRSF) Plans to Enter New Markets While Making EEGs More Accessible
Recent forecasts show telemedicine industry expected to experience CAGR of 15.1% through 2027 BRSF has potential to disrupt sleep industry, which is forecast to reach $585 billion by 2025
By InvestorBrandNetwork2 years ago in Longevity
Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Announces Film Bubble Partnership, New CFO Appointment
The film and television industry has seen a significant drop in revenue, and the Film Bubble is positioned to make sets safer with the technology provided by Draganfly Effective December 11, 2020, Mark Lotz took over the position of Chief Financial Officer after the resignation of Abbey Abdiye
By InvestorBrandNetwork2 years ago in Trader
PacRoots Cannabis Corp (CSE: PACR) (OTCBQ: PACRF) Announces Results of Initial Hemp CBD Harvest
Initial harvest yielded 105,000 lbs of biomass of exceptional quality; yield was sold in its entirety to Speakeasy Cannabis Club Harvest was particularly remarkable given that it was produced despite region’s poor prevailing weather conditions Global CBD oil, consumer health market poised to grow to value of $123.2 billion by 2027
By InvestorBrandNetwork2 years ago in Trader
Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) Looks for High-Growth Return as Junior Mining Investment Option
VanEck report details investment value of ‘junior’ mining companies Global smart mining market estimated to reach $6.8 billion last year, forecast to reach $20.31 billion by 2025
By InvestorBrandNetwork2 years ago in Trader
SRAX Inc. (NASDAQ: SRAX) Announces Extension of BIGtoken Special Dividend
If declared, special dividend will consist of number, designation determined by company management BIGtoken is first consumer-managed data marketplace where people can own, earn from their data
By InvestorBrandNetwork2 years ago in Trader
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moving Forward with New Berubicin Clinical Trials, Determined to Help Address Unmet Needs of GBM Patients
Company holds the exclusive worldwide license for Berubicin, the first anthracycline to cross the blood-brain barrier in the adult brain The GBM therapeutics market is expected to increase to an estimated $3.3 billion in 2024 CNS Pharmaceuticals’ sublicensee will be conducting the first pediatric study using Berubicin
By InvestorBrandNetwork2 years ago in Trader
